These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 19501646)
1. Disturbed distribution of proliferative brain cells during lupus-like disease. Stanojcic M; Burstyn-Cohen T; Nashi N; Lemke G; Sakic B Brain Behav Immun; 2009 Oct; 23(7):1003-13. PubMed ID: 19501646 [TBL] [Abstract][Full Text] [Related]
2. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. Ballok DA; Millward JM; Sakic B Brain Res; 2003 Feb; 964(2):200-10. PubMed ID: 12576180 [TBL] [Abstract][Full Text] [Related]
3. Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus. Ballok DA; Ma X; Denburg JA; Arsenault L; Sakic B J Rheumatol; 2006 Nov; 33(11):2199-213. PubMed ID: 17086606 [TBL] [Abstract][Full Text] [Related]
4. Hippocampal damage in mouse and human forms of systemic autoimmune disease. Ballok DA; Woulfe J; Sur M; Cyr M; Sakic B Hippocampus; 2004; 14(5):649-61. PubMed ID: 15301441 [TBL] [Abstract][Full Text] [Related]
5. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice. Anderson KK; Ballok DA; Prasad N; Szechtman H; Sakic B Behav Brain Res; 2006 Jan; 166(1):32-8. PubMed ID: 16183144 [TBL] [Abstract][Full Text] [Related]
6. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice. Ballok DA; Earls AM; Krasnik C; Hoffman SA; Sakic B J Neuroimmunol; 2004 Jul; 152(1-2):83-97. PubMed ID: 15223241 [TBL] [Abstract][Full Text] [Related]
7. Intrathecal antibodies and brain damage in autoimmune MRL mice. Stanojcic M; Loheswaran G; Xu L; Hoffman SA; Sakic B Brain Behav Immun; 2010 Feb; 24(2):289-97. PubMed ID: 19853033 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease? Sakic B; Kolb B; Whishaw IQ; Gorny G; Szechtman H; Denburg JA J Neuroimmunol; 2000 Nov; 111(1-2):93-101. PubMed ID: 11063826 [TBL] [Abstract][Full Text] [Related]
9. Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. Sakic B; Kirkham DL; Ballok DA; Mwanjewe J; Fearon IM; Macri J; Yu G; Sidor MM; Denburg JA; Szechtman H; Lau J; Ball AK; Doering LC J Neuroimmunol; 2005 Dec; 169(1-2):68-85. PubMed ID: 16198428 [TBL] [Abstract][Full Text] [Related]
10. Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice. Sidor MM; Sakic B; Malinowski PM; Ballok DA; Oleschuk CJ; Macri J J Neuroimmunol; 2005 Aug; 165(1-2):104-13. PubMed ID: 15972238 [TBL] [Abstract][Full Text] [Related]
12. Altered neuroendocrine status at the onset of CNS lupus-like disease. Loheswaran G; Kapadia M; Gladman M; Pulapaka S; Xu L; Stanojcic M; Sakic B Brain Behav Immun; 2013 Aug; 32():86-93. PubMed ID: 23466502 [TBL] [Abstract][Full Text] [Related]
13. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice. Wen J; Doerner J; Weidenheim K; Xia Y; Stock A; Michaelson JS; Baruch K; Deczkowska A; Gulinello M; Schwartz M; Burkly LC; Putterman C J Autoimmun; 2015 Jun; 60():40-50. PubMed ID: 25911200 [TBL] [Abstract][Full Text] [Related]
14. Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice. Ma X; Foster J; Sakic B J Neuroimmunol; 2006 Oct; 179(1-2):26-36. PubMed ID: 16904195 [TBL] [Abstract][Full Text] [Related]
15. Altered olfactory function in the MRL model of CNS lupus. Kapadia M; Stanojcic M; Earls AM; Pulapaka S; Lee J; Sakic B Behav Brain Res; 2012 Oct; 234(2):303-11. PubMed ID: 22796602 [TBL] [Abstract][Full Text] [Related]
16. Alterations in hypothalamic-pituitary-adrenal function correlated with the onset of murine SLE in MRL +/+ and lpr/lpr mice. Shanks N; Moore PM; Perks P; Lightman SL Brain Behav Immun; 1999 Dec; 13(4):348-60. PubMed ID: 10600221 [TBL] [Abstract][Full Text] [Related]
17. Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus. Sled JG; Spring S; van Eede M; Lerch JP; Ullal S; Sakic B Arthritis Rheum; 2009 Jun; 60(6):1764-74. PubMed ID: 19479832 [TBL] [Abstract][Full Text] [Related]
18. Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice. Zhou J; Lu F; Li S; Xie M; Lu H; Xie Z; Wu D; Wang S; Wen C; Xu ZH Inflammopharmacology; 2020 Apr; 28(2):425-435. PubMed ID: 31786803 [TBL] [Abstract][Full Text] [Related]
19. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus. Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816 [TBL] [Abstract][Full Text] [Related]
20. B and T cells in the brains of autoimmune mice. Zameer A; Hoffman SA J Neuroimmunol; 2004 Jan; 146(1-2):133-9. PubMed ID: 14698855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]